Fundraising FoxDiasome Pharmaceuticals
Cleveland, US · Delaware corporation · 2 known investors
Find your way into Diasome Pharmaceuticals
Sign up to see every warm intro you have to Diasome Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diasome Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RG
Robert GehoCo-founder
WB
W. Blair GehoCo-founder
HK
Helga KautskyExecutive
Board
Investors · 2
JDRF T1D FundreportedBoston
How we know: funding news · press coverage · Not right? Tell us
MedicxireportedLondon
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$49.6M disclosed across 7 rounds · 2016–2024
▶$3.1MraisedAug 2024 · 4 investors · Other Health CareRule 506(b)
▶$3.1MraisedAug 2024 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter TollmanDirector
- Robert GehoExecutive Officer, Director
- Frank McCaneyDirector
- W. Blair GehoExecutive Officer, Director
- Thomas McDonaldDirector
- Cosme OrdonezDirector
- Offering amount
- $15.6M
- Amount sold
- $3.1M
- Finders' fees
- $152.1K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedJun 2023 · 2 investors · OtherRule 506(b)
▶$9MraisedJun 2023 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thomas McDonaldDirector
- Peter TollmanDirector
- Robert GehoExecutive Officer, Director
- Marc PennDirector
- Frank McCaneyDirector
- W. Blair GehoDirector
- Offering amount
- $15M
- Amount sold
- $9M
- Finders' fees
- $350K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.7MraisedSep 2022 · 40 investors · BiotechnologyRule 506(b)
▶$16.7MraisedSep 2022 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marc PennDirector
- Robert GehoExecutive Officer, Director, Promoter
- Thomas McDonaldDirector
- W. Blair GehoDirector
- Frank McCaneyDirector
- Offering amount
- $19.1M
- Amount sold
- $16.7M
- Finders' fees
- $537.7K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedDec 2020 · 6 investors · BiotechnologyRule 506(b)
▶$1.5MraisedDec 2020 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GehoExecutive Officer, Director, Promoter
- Marc PennDirector
- Frank McCaneyDirector
- W. Blair GehoDirector
- Thomas McDonaldDirector
- Offering amount
- $5M
- Amount sold
- $1.5M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedApr 2020 · 20 investors · BiotechnologyRule 506(b)
▶$2.9MraisedApr 2020 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marc PennDirector
- Robert GehoExecutive Officer, Director, Promoter
- W. Blair GehoDirector
- Frank McCaneyDirector
- Thomas McDonaldDirector
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.1MraisedOct 2018 · 22 investors · BiotechnologyRule 506(b)
▶$12.1MraisedOct 2018 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GehoExecutive Officer, Director
- Thomas McDonaldDirector
- Marc PennDirector
- Frank McCaneyDirector
- W. Blair GehoDirector
- Offering amount
- $18.6M
- Amount sold
- $12.1M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedJan 2017 · 4 investors · PharmaceuticalsRule 506(b)
▶$4.3MraisedJan 2017 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michele OllierDirector
- Thomas McDonaldDirector
- Helga KautskyExecutive Officer
- Frank McCaneyDirector
- Robert GehoExecutive Officer, Director
- Guiseppe ZoccoDirector
- W. Blair GehoDirector
- Richard CarusoDirector
- Offering amount
- $8M
- Amount sold
- $4.3M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Diasome Pharmaceuticals?
- Diasome Pharmaceuticals was founded by Robert Geho, W. Blair Geho.
- Who are Diasome Pharmaceuticals's investors?
- Diasome Pharmaceuticals's investors include JDRF T1D Fund, Medicxi.
- How much funding has Diasome Pharmaceuticals raised?
- Diasome Pharmaceuticals has disclosed $49.6M raised across 7 rounds.
- Where is Diasome Pharmaceuticals headquartered?
- Diasome Pharmaceuticals is headquartered in Cleveland, US.